Children
411
59
80
217
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
17 trials with published results (4%)
Research Maturity
217 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
10 terminated out of 411 trials
95.6%
+9.1% vs benchmark
9%
38 trials in Phase 3/4
8%
17 of 217 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 217 completed trials
Clinical Trials (411)
Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy
Cognitive Neuroscience of Autism Spectrum Disorders
Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congenital Heart Disease Undergoing Surgical Repair
Effects of 8-Week CrossFit-Based Concurrent Training on Fitness, Body Composition, and Psychological Outcomes in Schoolchildren
Predicting Vaccine Hesitancy Using Machine Learning
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
Cerebral Palsy and the Study of Brain Activity During Motor Tasks
Comparing Game-Based Reward Systems to Support Children's Engagement:
Differentiate Children Septic and Inflammatory Arthritis by Comparative Analysis
Autoimmune Hyperthyroidism in Prepubertal Children
An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
Realizing Effectiveness Across Continents With Hydroxyurea
Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.
An Intervention-Based Approach to Strengthen the Psychological Health of Children With Cystic Fibrosis and Their Mothers
Evaluation of a Multicomponent Early Intervention for Childhood Obesity Prevention in Vulnerable Families
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children